Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	51.85	71.08	88.46	110.89	136.38	39.55
Cash & Short-Term Investments	51.85	71.08	88.46	110.89	136.38	39.55
Cash Growth	-30.66%	-19.64%	-20.23%	-18.69%	244.79%	214.39%
Other Receivables	-	-	-	0.74	1.07	0.64
Receivables	-	-	-	0.74	1.07	0.64
Inventory	3.14	2.1	1.49	5.25	-	-
Prepaid Expenses	0.24	0.7	1.3	1.21	2.49	1.81
Restricted Cash	0.11	0.11	0.11	0.11	0.11	0.11
Other Current Assets	0.34	0.47	0.87	-	1.19	0.66
Total Current Assets	55.68	74.46	92.22	118.2	141.24	42.77
Property, Plant & Equipment	-	-	-	-	-	0.04
Long-Term Investments	-	-	1.71	4.7	-	-
Other Intangible Assets	-	-	-	-	-	0.01
Other Long-Term Assets	2.33	1.99	2.32	0.64	0.02	0.02
Total Assets	58.01	76.44	96.25	123.53	141.26	42.84
Accounts Payable	3.54	0.68	0.81	2.97	1.72	1.59
Accrued Expenses	3.11	2.78	2.63	2.58	1.39	1.06
Current Portion of Leases	-	-	-	-	-	0.02
Other Current Liabilities	1.58	1.51	1.8	0.02	0.02	13.01
Total Current Liabilities	8.23	4.97	5.24	5.57	3.13	15.67
Total Liabilities	8.23	4.97	5.24	5.57	3.13	15.67
Common Stock	23.49	23.49	22.79	22.79	22.79	8.56
Additional Paid-In Capital	263.4	261.26	255.99	251.37	244	129.89
Retained Earnings	-235.63	-211.79	-186.29	-156.19	-129.23	-111.9
Treasury Stock	-1.48	-1.48	-1.48	-	-	-
Total Common Equity	49.79	71.48	91.02	117.96	137.55	26.55
Shareholders' Equity	49.79	71.48	91.02	117.96	138.14	27.17
Total Liabilities & Equity	58.01	76.44	96.25	123.53	141.26	42.84
Total Debt	-	-	-	-	-	0.02
Net Cash (Debt)	51.85	71.08	88.46	110.89	136.38	39.54
Net Cash Growth	-30.66%	-19.64%	-20.23%	-18.69%	244.94%	215.51%
Net Cash Per Share	6.05	8.47	10.52	13.14	17.49	52.44
Filing Date Shares Outstanding	8.61	8.61	8.35	8.44	8.44	8.05
Total Common Shares Outstanding	8.61	8.61	8.35	8.44	8.44	3.17
Working Capital	47.45	69.49	86.98	112.63	138.11	27.1
Book Value Per Share	5.78	8.30	10.90	13.97	16.29	8.37
Tangible Book Value	49.79	71.48	91.02	117.96	137.55	26.53
Tangible Book Value Per Share	5.78	8.30	10.90	13.97	16.29	8.37
Machinery	-	-	-	-	-	0.19

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q